Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by M.K. Rasmussen
Safety, Efficacy, and Drug Survival of Biologics and Biosimilars for Moderate-To-Severe Plaque Psoriasis
British Journal of Dermatology
Dermatology
Medicine
生物制剂和生物仿制药对中度至重度斑块状银屑病患者的安全性、疗效和药物存活率
British Journal of Dermatology
Dermatology
Medicine
Related publications
Ixekizumab Efficacy and Safety in Moderate-To-Severe Genital Psoriasis
British Journal of Dermatology
Dermatology
Medicine
Efficacy and Safety of Continuous Risankizumab Therapy vs Treatment Withdrawal in Patients With Moderate to Severe Plaque Psoriasis
JAMA Dermatology
Dermatology
Medicine
Efficacy and Safety Observed During 24 Weeks of Efalizumab Therapy in Patients With Moderate to Severe Plaque Psoriasis
Archives of Dermatology
Safety and Efficacy of Guselkumab in Japanese Patients With Moderate-To-Severe Plaque Psoriasis: A Randomised, Placebo-Controlled, Ascending Dose Study
British Journal of Dermatology
Dermatology
Medicine
Efficacy and Safety of Mirikizumab (LY3074828) in the Treatment of Moderate-To-Severe Plaque Psoriasis: Results From a Randomised Phase 2 Study
British Journal of Dermatology
Dermatology
Medicine
Randomized, Controlled Study of Bleselumab (ASKP1240) Pharmacokinetics and Safety in Patients With Moderate-To-Severe Plaque Psoriasis
Biopharmaceutics and Drug Disposition
Medicine
Pharmacology
Pharmaceutical Science
Psy103 - Modelling Average Cost and Cost-Per-Responder for Biological Treatments for Moderate-To-Severe Plaque Psoriasis With Dose Escalation and Real-World Drug Survival
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Costs of Treatment in Patients With Moderate to Severe Plaque Psoriasis
Archives of Dermatology
Effectiveness and Safety of Targeted Drugs for the Treatment of Adults With Moderate-To-Severe Plaque Psoriasis in the Russian Federation
Medical Technologies. Assessment and Choice (Медицинские технологии. Оценка и выбор)
